Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03986138 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
A Phase 3 study of Lesion in Body Region, sponsored by Guerbet.
- Completed
- Registry status
- Phase 3
- Development phase
- 324
- Enrollment target
- 20
- Study locations
NCT03986138 is a Phase 3 study of Lesion in Body Region that has completed, run by Guerbet. The registered enrollment target is 324 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT03986138, a Phase 3 study of Lesion in Body Region, has completed, sponsored by Guerbet.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 324 participants
- Enrollment target
- 20
- Study locations
Study Summary
The trial aimed at evaluating the efficacy and the safety of gadopiclenol for body Magnetic resonance Imaging (MRI)
Conditions Studied
Interventions
- DRUG gadopiclenol
- DRUG Gadobutrol 1 MMOLE/ML Intravenous Solution
Study Locations (20)
Other
- Acibadem City Clinic Tokuda Hospital Sofia - Sofia
- CHU - Angers
- CHU Beaujon - Clichy
- Hôpital Saint Louis - Paris
- Klinik für Diagnostische und Interventionelle Radiologie - Aachen
- Universitätsklinikum Halle - Halle
- Universitätsklinikum des Saarlandes - Homburg
- University Hospital Jena - Jena
- Somogy Megyei Kaposi Mor Oktato Korhaz - Kaposvár
- Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet - Szolnok
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" - Naples
- Clinical Research Institute S.C. - Estado de México
- Axis Heilsa S de R.L. de C.V - Althian Clinical Research Management Center - Monterrey
Alabama
- The University of Alabama at Birmingham - Birmingham
Connecticut
- UConn Health - University of Connecticut - Farmington
Illinois
- The University of Chicago Medical Center - Chicago
Massachusetts
- Boston Medical Center - Boston
Missouri
- University of Missouri Health System - Columbia
New York
- Montefiore Medical Center - The Bronx
Texas
- UT Health San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2020-12-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03986138
The ClinicalTrials.gov registry entry for NCT03986138 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guerbet, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lesion in Body Region appearing as the primary indexed condition, and to 2 interventions - of which gadopiclenol is the first listed.
NCT03986138 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Other, Alabama, Connecticut.
Frequently Asked Questions
What is clinical trial NCT03986138 about?
NCT03986138 is a clinical study titled "Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)". The trial aimed at evaluating the efficacy and the safety of gadopiclenol for body Magnetic resonance Imaging (MRI)
What is the current status of trial NCT03986138?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 324 participants. The study started on 2019-08-27. Estimated completion is 2020-12-09.
What conditions does trial NCT03986138 study?
This clinical trial studies the following conditions: Lesion in Body Region.
What interventions are being tested in trial NCT03986138?
The interventions under investigation include: gadopiclenol (DRUG), Gadobutrol 1 MMOLE/ML Intravenous Solution (DRUG).
Who is sponsoring clinical trial NCT03986138?
This trial is sponsored by Guerbet, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03986138 being conducted?
This trial has 20 study locations across Alabama, Connecticut, Illinois, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.